News
FECCIA
Other
CEFIC Publishes 2024 Facts and Figures Report
CEFIC , the European Chemical Industry Council, has published its 2024 Facts & Figures report, which reinforces the need to take bold and urgent action to secure Europe’s industrial future, not only to implement the Green Deal but also to prevent further de-industrialization in Europe.
Heraeus Acquires Umicore’s Platinum API Business outside of South America
In a move to strengthen its position and product portfolio, Heraeus has announced the acquisition of Umicore's business with platinum-containing active pharmaceutical ingredients (APIs) outside South America. With immediate effect, the business is transferred to Heraeus Precious Metals, the group's precious metals division.
BASF Divests Food and Health Performance Ingredients Business to Louis Dreyfus Company
BASF has signed a binding agreement to sell its Food and Health Performance Ingredients business, including the production site in Illertissen, Germany, to Louis Dreyfus Company (LDC), a Dutch merchant and processor of agricultural goods.
Sanofi to Invest $1 Billion in New Insulin Manufacturing Site in China
Sanofi plans to invest around €1 billion ($1.1 billion) in the construction of a new insulin production facility in Beijing – the company's largest single investment in China to date. This was reported by Reuters and other news agencies.
Arkema Acquires Dow's Flexible Packaging Laminating Adhesives Business
Arkema recently finalized the acquisition of Dow’s flexible packaging laminating adhesives business. This acquisition will significantly expand Arkema's portfolio of solutions for flexible packaging, positioning the company as a key player in this attractive market.
Novartis Acquires Kate Therapeutics for $1.1 Billion
Swiss pharmaceutical giant Novartis has acquired Kate Therapeutics for $1.1 billion. The San Diego, US-headquartered preclinical stage biotechnology company develops adeno-associated virus (AAV)-based gene therapies to treat inherited neuromuscular diseases.